Camptothecin, an inhibitor of cellular nucleic acid synthesis, prevents fowl plague virus replication in BHK 2~/I3 cells. In the presence of camptothecin the synthesis of haemagglutinin and neuraminidase antigens does not occur; the ribonucleoprotein antigen is synthesized and accumulates only in the cell nucleus; and the synthesis of virus-specific RNA (of which complementary RNA predominates) is reduced considerably.
INTRODUCTION
Influenza virus is unable to replicate in enucleate cells (Follett et al. I974; Kelly, Avery & Dimmock, I974) and replication in nucleate cells is prevented by actinomycin D or mitomycin C treatment before, or early in, infection (Barry, I964; Rott, Saber & Scholtissek, I965; Kelly & Dimmock, I974) . This may be explained by postulating that a nuclear DNA-dependent RNA polymerase, or a part of it, plays a role in influenza virus replication (Borland & Mahy, I968) , and recent experiments by Mahy and colleagues (Mahy, Hastie & Armstrong, I972; Mahy et al. 1973 ) using c~-amanitin and cordycepin suggest that nucleoplasmic DNA-dependent RNA polymerase II is involved. Alternatively the requirement may be for a host coded product (Rottet al. I965; White et al. I965; Kelly et aL I974; Kelly & Dimmock, I974) . The drugs used in these studies (~-amanitin, cordycepin, actinomycin D, and mitomycin C) have the disadvantage that their effect is essentially irreversible, and that they act by binding to DNA or polymerases. Camptothecin, an alkaloid derived from a Tibetan shrub, Camptotheca acuminata, inhibits RNA and DNA synthesis in mammalian cells by cleaving DNA, and does not directly affect polymerase activities (Wall et aL I966; Bosmann, 197o; Horwitz & Horwitz, I97I; Kessell & Dysard, I973 .) The drug is claimed to be easily reversible because the nicked or cleaved DNA is rapidly repaired by ligases (Horwitz & Brayton, I972). As such the drug appeared a useful probe to investigate the dependence of influenza virus on the integrity of the cell genome, and to investigate the point in influenza virus replication at which this dependence is manifest. Virus growth, assay and infection of cells. Fowl plague virus, A/FRV/Rostock/34 HavNi was grown in ova, titrated by haemagglutination, and plaque assayed in primary chick embryo fibroblasts as previously described (Avery, 1974; Kelly et al. I974) . Influenza virus replication was studied in BHK 2I/r 3 cells. These cells were grown in 5 or I3 cm plastic Petri dishes seeded with 3 × Io6 or 2 × IO 7 cells/dish, respectively and allowed to grow overnight. The cells were infected by allowing virus (Io p.f.u./cell) to adsorb to naked cell sheets for 45 rain. Infection was then allowed to proceed by adding 3 or 20 ml of Eagle's medium supplemented with tryptose phosphate broth and foetal calf serum and incubating at 37 °C.
Radioactive labelling of cells. Infected and mock-infected ceils were radioactively labelled by removing the growth medium from cell sheets and r,.placing with I or 7 ml (in the case of 5 or I3 cm Petri dishes) Earle's saline supplemented with 2 % dialysed foetal calf serum containing 5o #Ci isotope per ml. Labelling was carried out for I h.
Acrylamide gel electrophoresis and autoradiography. This was performed as described by Kelly et al. (I974) . Electrophoresis was performed on IO% SDS gels. Iooooo ct/min of material was routinely added to each gel.
Preparation of specific antisera and fluorescent antibody staining was performed as previously described (Kelly et al. 1974) .
Extraction of RNA from BHK cells and fowl plague virus was carried out as described by Avery (~t974) and Kelly et al. (I974) .
RNA-RNA hybridization. This was performed essentially as described by Avery (I974).
[3H]-uridine-labelled RNA preparations were dissolved in o.o2 × SSC (SSC = o. 15 M-NaC1. o'oi5 M-trisodiurn citrate) and denatured by heating at 98 °C for 4 min. The sample was then brought to 6 × SSC at 65 °C rapidly and was incubated at 65 °C for 24o rain. The total sample vol. was 25o td. When appropriate, 15 #g of cold virus RNA was added at zero time.
Samples were taken at zero time and at 24 ° min by diluting in distilled water to adjust to I × SSC. Pancreatic and T1 ribonuclease were added to a final concentration of 5o/zg and I7o units]ml, respectively, and incubation was at 37 °C for 2o min. The reaction was stopped by the addition of 25o/zg of carrier yeast RNA and an equal vol. of ice-cold Io % trichloroacetic acid. Samples were also precipitated without prior enzyme treatment to determine the acid-precipitable radioactivity. Precipitates were collected on cellulose acetate filters and were washed twice with ice-cold 5 % trichloroacetic acid and twice with ether. The filters were dried and assayed for radioactivity.
RESULTS

The production of influenza virus haemagglutinin in the presence of camptothecin
Fig . I shows the effect of pre-treating BHK cells with varying amounts of camptothecin on their ability to produce fowl plague virus haemagglutinin (tested 7 h post-infection (p.i.)). It can readily be seen that camptothecin is an efficient inhibitor of influenza virus replication. Table I shows the effect of adding camptothecin after infection, and the drug is most effective if added before 4 h p.i. The action of the drug was only partially reversible.
Influenza virus-specific protein synthesis in camptothecin treated cells
Previously we have shown that in BHK cells infected with fowl plague virus the ribonucleoprotein antigen is first detected in the nucleus (about 3 h p.i.) and that this antigen subsequently appears to migrate from the nucleus to the cytoplasm (about 3½ h p.i.), and is then detected only in the cytopIasm for the remainder of the infection (Kelly & Dimmock, I974) . Two other virus structural antigens (the haernagglutinin and the neuraminidase, are .2 34"6 676o 3"9 2.8 978o 5"9 2"7 5570 6"5 I"7 1234o 7"2 2"5 58IO 4"4 3"2 I0280 6.I 2"8 6 880 63 2,7 9o6o 4"8 3'7 2600 4"7 7'5 * 15 #g camptothecin/ml (total 3 ml/3 × Io 6 cells/5 cm Petri dish) for time period. t Cells were pulsed with [5-3H]-uridine for 1 h prior to sampling. Mean of duplicate determinations of material insoluble in to ~ trichloroacetic acid. § Values corrected for annealing obtained with uninfected controls.
Virus-specific RNA synthesis in camptothecin treated cells
Since camptothecin had a marked effect on the synthesis of influenza virus-specific proteins in cells, we examined the synthesis of virus-specific R N A in cells treated with the drug. The results are presented in Table 2 . In cells untreated with camptothecin excess complementary R N A (cRNA) was synthesized early (2 h) in infection (indicated by the percentage R N A annealing with virus particle R N A compared to the lower percentage selfannealing). Later in infection (4 and 7 h) the proportion of virus particle R N A (vRNA) rises, as previously reported by Avery (1974) 
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acid insoluble [3H]-uridine-labelled material). Virus RNA synthesis was preferentially inhibited by the drug at all times tested as is shown by the reduced annealing. In addition the virus-specific RNA synthesis that did occur was predominantly cRNA. However, treatment of infected cells 4 h after infection (Table 2 bottom line) although reducing both total and virus-specific RNA synthesis, apparently did not alter the relative proportions of vRNA and cRNA (compared to an untreated control) possibly because the synthesis of vRNA was already well established at this point.
DISCUSSION
It is apparent that camptothecin is an efficient inhibitor of the production of influenza virus haemagglutinin in infected cells. Unlike other inhibitors of influenza virus replication camptothecin permits the syrrCthesis of certain virus-specific antigens and polypeptides (notably the ribonucleoprotein, NP, antigen and polypeptide) in amounts equivalent to untreated cells although virus-specific RNA synthesis is considerably reduced. The NP antigen accumulates in and remains associated with the nucleus whereas in productive infection it leaves the nucleus. The effect of camptothecin appears to be the inhibition of late functions of influenza virus in the infected cell. This cannot be correlated with a switch from cRNA to vRNA since both types of RNA are synthesized in the presence of the drug (in altered proportions). It is not yet known whether cRNA and vRNA synthesized in the presence of camptothecin represents the whole genome.
